Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-19-032833

Director sold 10,000 shares at $120.00 ($1,200,000)

  • Director acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Wigzell Hans Lennart Rudolf · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-05-23 Exercise or conversion : show line 1 in the form +10,000 $7.80 $78,000 21,717 D
2019-05-23 Sale : show line 2 in the form −10,000 $120.00 $1,200,000 11,717 D
Open-market sales · 10,000 sh · avg $120.00 · $1,200,000

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-05-23 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −10,000 $7.80 2020-06-08 10,000 0 D
Loading xslF345X03/doc4.xml…